The bill strengthens consumer safety, worker protections, animal welfare, and government oversight around nonambulatory pigs at the expense of added compliance costs, enforcement burdens, and potential supply/price impacts that fall hardest on producers, small transporters, and small slaughter establishments.
Consumers and public health systems: the bill largely bars nonambulatory pigs from the food supply and requires humane handling/euthanasia, reducing the risk of foodborne illness and related hospitalizations.
Farm, transport, and slaughter workers: the bill strengthens workplace safety through OSHA training/standards, clearer covered-person status, and explicit whistleblower protections, making it easier and safer for workers to report unsafe or inhumane practices.
Pigs (animal welfare) and livestock owners who follow standards: the bill establishes humane-euthanasia requirements, transport/handling standards, and bans certain growth-promoting beta-adrenergic agonists, improving animal welfare and reducing stress-linked injuries.
Producers, transporters, and small slaughterhouses: the bill imposes new euthanasia, testing, transport, housing, recordkeeping, and training requirements that raise operating and compliance costs.
Consumers and producers: excluding nonambulatory animals from processing, mandatory testing/condemnation, and reduced production efficiency (from the beta-agonist ban) could shrink marketable supply and increase retail pork prices.
Small transporters and small slaughter establishments: strict equipment, temperature, space, and other standards with a short compliance timeline risk operational disruption, closures, or industry consolidation.
Based on analysis of 8 sections of legislative text.
Bars nonambulatory pigs from the food supply, restricts certain drugs, requires humane handling, OSHA safety rules, a complaint portal, whistleblower protections, and a USDA/CDC pathogen study.
Introduced July 25, 2025 by Veronica Escobar · Last progress July 25, 2025
Prohibits nonambulatory pigs and their carcasses from entering the food supply, sets new handling, transport, euthanasia, inspection, and recordkeeping rules for pigs that cannot stand or walk, and restricts use of beta-adrenergic agonist drugs except to treat disease. Requires USDA/FSIS and OSHA rulemaking (deadlines within 1–2 years), creates a confidential online complaint portal and whistleblower protections for workers, and directs a public-health study on pathogens linked to nonambulatory pigs.